TY - JOUR
T1 - Influences of ventricular assist device pumping on blood coagulation
AU - Taenaka, Y.
AU - Matsuda, T.
AU - Takano, H.
AU - Umezu, M.
AU - Akutsu, T.
PY - 1989
Y1 - 1989
N2 - A left ventricular assist device (VAD) with a smooth surface of segmented polyurethane was implanted in five goats for 10-55 days, and plasma levels of fibrinogen (Fg), prekallikrein (PK), fibrinogen, fibrin degradation products (FDP), antithrombin III (AT III), prothrombin time (PT), partial thromboplastin time (PTT), platelet (PI) count, and platelet aggregation (PIAg) induced by adenosine diphosphate were measured during the experiment. Heparin was administered during surgery and no systemic antithrombotic therapy was given thereafter. Before the third postoperative day (POD), plasma levels of Fg and PK were at their lowest, and increased afterward. Between the second and fifth POD PT and PTT increased to 130-160%, and returned to normal gradually. Plasma FDP appeared on the second POD and reached peak values of 10-40 μg/ml on the sixth POD. Platelet and AT III levels showed no uniform tendency, but the rate of PIAg decreased to levels of 6-77% before the fifth POD and remained low at approximately 80%, influenced by the pumping even after the 25th POD. In summary, VADs the themselves activated coagulation and induced consumption coagulopathy to some degree. However, most of the parameters returned to normal within 2 weeks.
AB - A left ventricular assist device (VAD) with a smooth surface of segmented polyurethane was implanted in five goats for 10-55 days, and plasma levels of fibrinogen (Fg), prekallikrein (PK), fibrinogen, fibrin degradation products (FDP), antithrombin III (AT III), prothrombin time (PT), partial thromboplastin time (PTT), platelet (PI) count, and platelet aggregation (PIAg) induced by adenosine diphosphate were measured during the experiment. Heparin was administered during surgery and no systemic antithrombotic therapy was given thereafter. Before the third postoperative day (POD), plasma levels of Fg and PK were at their lowest, and increased afterward. Between the second and fifth POD PT and PTT increased to 130-160%, and returned to normal gradually. Plasma FDP appeared on the second POD and reached peak values of 10-40 μg/ml on the sixth POD. Platelet and AT III levels showed no uniform tendency, but the rate of PIAg decreased to levels of 6-77% before the fifth POD and remained low at approximately 80%, influenced by the pumping even after the 25th POD. In summary, VADs the themselves activated coagulation and induced consumption coagulopathy to some degree. However, most of the parameters returned to normal within 2 weeks.
UR - http://www.scopus.com/inward/record.url?scp=0024706071&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024706071&partnerID=8YFLogxK
U2 - 10.1097/00002480-198907000-00072
DO - 10.1097/00002480-198907000-00072
M3 - Article
C2 - 2597487
AN - SCOPUS:0024706071
SN - 0889-7190
VL - 35
SP - 396
EP - 398
JO - ASAIO Transactions
JF - ASAIO Transactions
IS - 3
ER -